Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Metastatic Castration-resistant Prostate Cancer (mCRPC) × abiraterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 11 Urogenital Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Bulbo-Spinal Atrophy, X-Linked 1 Adenocarcinoma 1

Interventions

radium Ra 223 dichloride 1 niraparib 1 enzalutamide 1 darolutamide 1 capivasertib 1 cabazitaxel 1 apalutamide 1 abiraterone 1 Solutions 1 Prednisone 1 Injections 1 Docetaxel 1 Carboplatin 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03903835 2025-04-09

ProBio

Karolinska Institutet

Phase 3 Recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡